Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Semaglutide

SURMOUNT-5

Novo Nordisk · Phase 3 · Completed · Enrollment 751

NCT05822830

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
15 mg or MTD - Tirzepatide163 participants56 participants88 participantsn/r0
2.4 mg or MTD - Semaglutide167 participants80 participants88 participantsn/r0

A count stays a count. This page does not turn a count into a percent.